Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The book is a comprehensive resource on hair disorders, but lacks information on some conditions.

Hair loss may increase heart disease risk.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Many late adolescent girls lack knowledge and have negative attitudes about PCOS.

Exercise, especially vigorous aerobic and resistance training, can improve hormone levels in women with PCOS.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Semaglutide helps obese PCOS patients lose weight and improve health.

Ginger and cinnamon can help manage PCOS and related disorders by reducing oxidative stress and inflammation.

Probiotics and synbiotics might help manage hirsutism by improving insulin resistance.

Sex hormones affect liver fat and metabolic health differently in men and women.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Nanomaterials could improve PCOS treatment by delivering drugs more effectively with fewer side effects.

Alopecia areata patients have a higher risk of subclinical atherosclerosis, and carotid ultrasound can help assess their cardiovascular risk.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Skin changes in obesity can indicate metabolic issues but aren't reliable for assessing risk or monitoring treatment.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

The free androgen index varies among women with different types of PCOS.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Men with male pattern baldness have higher blood sugar, bad cholesterol, and ZAG protein levels than healthy men.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

A 16-year-old girl with HAIR-AN syndrome was treated with lifestyle changes and medications to manage her condition.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Ovarian hyperthecosis can cause symptoms even with normal testosterone levels, and surgery can improve these symptoms.

Quercetin may help improve symptoms of polycystic ovary syndrome.